Association of obesity, visceral adiposity, and sarcopenia with an increased risk of metabolic syndrome: A retrospective study.

<h4>Aims</h4>Metabolic syndrome (MS) is a global health problem associated with an increased risk of diabetes mellitus (DM), cardiovascular disease (CVD), and cancer. Body composition parameters, including obesity, visceral adiposity, and sarcopenia contribute to the development of MS an...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Su Hwan Kim, Hyoun Woo Kang, Ji Bong Jeong, Dong Seok Lee, Dong-Won Ahn, Ji Won Kim, Byeong Gwan Kim, Kook Lae Lee, Sohee Oh, Soon Ho Yoon, Sang Joon Park
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/4228f171d8f7455bb0344a25f65fe9b6
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:4228f171d8f7455bb0344a25f65fe9b6
record_format dspace
spelling oai:doaj.org-article:4228f171d8f7455bb0344a25f65fe9b62021-12-02T20:18:00ZAssociation of obesity, visceral adiposity, and sarcopenia with an increased risk of metabolic syndrome: A retrospective study.1932-620310.1371/journal.pone.0256083https://doaj.org/article/4228f171d8f7455bb0344a25f65fe9b62021-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0256083https://doaj.org/toc/1932-6203<h4>Aims</h4>Metabolic syndrome (MS) is a global health problem associated with an increased risk of diabetes mellitus (DM), cardiovascular disease (CVD), and cancer. Body composition parameters, including obesity, visceral adiposity, and sarcopenia contribute to the development of MS and CVD. Previous studies have investigated the association of individual body composition parameters with MS. Studies analyzing the association between multiple body composition parameters and MS have been rare. We aimed to investigate the association between MS and multiple body composition parameters, including obesity, visceral adiposity, and sarcopenia.<h4>Methods</h4>A total of 13,620 subjects who underwent voluntary routine checkups at the Health Care Center of our institution between October 2014 and December 2019 were enrolled. Only data from the first examination of subjects who underwent repeated checkups were included. Clinical and laboratory data were collected. Skeletal muscle mass and visceral fat area (VFA) were measured using bioelectrical impedance analysis. Appendicular skeletal muscle mass (ASM) was divided by body weight (in kg) and expressed as a percentage (calculated as, ASM% = ASM × 100/Weight). Data were compared between the groups based on obesity, VFA, and ASM%. Logistic regression analysis was performed to determine the risk of MS in each group.<h4>Results</h4>Body mass index and VFA were significantly higher in subjects with MS than in those without MS. ASM% was significantly lower in subjects with MS than in those without MS. Subjects with obesity, visceral adiposity, or sarcopenia had a higher prevalence of MS than those without. As the number of metabolic components increased from 0 to 5, we identified a decreasing trend of ASM% and an increasing trend of VFA and BMI (P for trend < 0.001 for all). In the paired analyses, all the three body composition parameters showed additive effects in predicting MS. In the logistic regression analysis, the three parameters were associated with an increased risk of MS after adjustment for age, sex, hypertension, DM, dyslipidemia, smoking, alcohol intake, and C-reactive protein.<h4>Conclusions</h4>Obesity, visceral adiposity, and sarcopenia showed additive effects on MS prediction. Subjects with obesity, visceral adiposity, or sarcopenia were significantly associated with the increased risk of MS after adjustment for multiple confounders. Increasing skeletal muscle and reducing visceral fat may be strategies for the prevention or treatment of MS.Su Hwan KimHyoun Woo KangJi Bong JeongDong Seok LeeDong-Won AhnJi Won KimByeong Gwan KimKook Lae LeeSohee OhSoon Ho YoonSang Joon ParkPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 8, p e0256083 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Su Hwan Kim
Hyoun Woo Kang
Ji Bong Jeong
Dong Seok Lee
Dong-Won Ahn
Ji Won Kim
Byeong Gwan Kim
Kook Lae Lee
Sohee Oh
Soon Ho Yoon
Sang Joon Park
Association of obesity, visceral adiposity, and sarcopenia with an increased risk of metabolic syndrome: A retrospective study.
description <h4>Aims</h4>Metabolic syndrome (MS) is a global health problem associated with an increased risk of diabetes mellitus (DM), cardiovascular disease (CVD), and cancer. Body composition parameters, including obesity, visceral adiposity, and sarcopenia contribute to the development of MS and CVD. Previous studies have investigated the association of individual body composition parameters with MS. Studies analyzing the association between multiple body composition parameters and MS have been rare. We aimed to investigate the association between MS and multiple body composition parameters, including obesity, visceral adiposity, and sarcopenia.<h4>Methods</h4>A total of 13,620 subjects who underwent voluntary routine checkups at the Health Care Center of our institution between October 2014 and December 2019 were enrolled. Only data from the first examination of subjects who underwent repeated checkups were included. Clinical and laboratory data were collected. Skeletal muscle mass and visceral fat area (VFA) were measured using bioelectrical impedance analysis. Appendicular skeletal muscle mass (ASM) was divided by body weight (in kg) and expressed as a percentage (calculated as, ASM% = ASM × 100/Weight). Data were compared between the groups based on obesity, VFA, and ASM%. Logistic regression analysis was performed to determine the risk of MS in each group.<h4>Results</h4>Body mass index and VFA were significantly higher in subjects with MS than in those without MS. ASM% was significantly lower in subjects with MS than in those without MS. Subjects with obesity, visceral adiposity, or sarcopenia had a higher prevalence of MS than those without. As the number of metabolic components increased from 0 to 5, we identified a decreasing trend of ASM% and an increasing trend of VFA and BMI (P for trend < 0.001 for all). In the paired analyses, all the three body composition parameters showed additive effects in predicting MS. In the logistic regression analysis, the three parameters were associated with an increased risk of MS after adjustment for age, sex, hypertension, DM, dyslipidemia, smoking, alcohol intake, and C-reactive protein.<h4>Conclusions</h4>Obesity, visceral adiposity, and sarcopenia showed additive effects on MS prediction. Subjects with obesity, visceral adiposity, or sarcopenia were significantly associated with the increased risk of MS after adjustment for multiple confounders. Increasing skeletal muscle and reducing visceral fat may be strategies for the prevention or treatment of MS.
format article
author Su Hwan Kim
Hyoun Woo Kang
Ji Bong Jeong
Dong Seok Lee
Dong-Won Ahn
Ji Won Kim
Byeong Gwan Kim
Kook Lae Lee
Sohee Oh
Soon Ho Yoon
Sang Joon Park
author_facet Su Hwan Kim
Hyoun Woo Kang
Ji Bong Jeong
Dong Seok Lee
Dong-Won Ahn
Ji Won Kim
Byeong Gwan Kim
Kook Lae Lee
Sohee Oh
Soon Ho Yoon
Sang Joon Park
author_sort Su Hwan Kim
title Association of obesity, visceral adiposity, and sarcopenia with an increased risk of metabolic syndrome: A retrospective study.
title_short Association of obesity, visceral adiposity, and sarcopenia with an increased risk of metabolic syndrome: A retrospective study.
title_full Association of obesity, visceral adiposity, and sarcopenia with an increased risk of metabolic syndrome: A retrospective study.
title_fullStr Association of obesity, visceral adiposity, and sarcopenia with an increased risk of metabolic syndrome: A retrospective study.
title_full_unstemmed Association of obesity, visceral adiposity, and sarcopenia with an increased risk of metabolic syndrome: A retrospective study.
title_sort association of obesity, visceral adiposity, and sarcopenia with an increased risk of metabolic syndrome: a retrospective study.
publisher Public Library of Science (PLoS)
publishDate 2021
url https://doaj.org/article/4228f171d8f7455bb0344a25f65fe9b6
work_keys_str_mv AT suhwankim associationofobesityvisceraladiposityandsarcopeniawithanincreasedriskofmetabolicsyndromearetrospectivestudy
AT hyounwookang associationofobesityvisceraladiposityandsarcopeniawithanincreasedriskofmetabolicsyndromearetrospectivestudy
AT jibongjeong associationofobesityvisceraladiposityandsarcopeniawithanincreasedriskofmetabolicsyndromearetrospectivestudy
AT dongseoklee associationofobesityvisceraladiposityandsarcopeniawithanincreasedriskofmetabolicsyndromearetrospectivestudy
AT dongwonahn associationofobesityvisceraladiposityandsarcopeniawithanincreasedriskofmetabolicsyndromearetrospectivestudy
AT jiwonkim associationofobesityvisceraladiposityandsarcopeniawithanincreasedriskofmetabolicsyndromearetrospectivestudy
AT byeonggwankim associationofobesityvisceraladiposityandsarcopeniawithanincreasedriskofmetabolicsyndromearetrospectivestudy
AT kooklaelee associationofobesityvisceraladiposityandsarcopeniawithanincreasedriskofmetabolicsyndromearetrospectivestudy
AT soheeoh associationofobesityvisceraladiposityandsarcopeniawithanincreasedriskofmetabolicsyndromearetrospectivestudy
AT soonhoyoon associationofobesityvisceraladiposityandsarcopeniawithanincreasedriskofmetabolicsyndromearetrospectivestudy
AT sangjoonpark associationofobesityvisceraladiposityandsarcopeniawithanincreasedriskofmetabolicsyndromearetrospectivestudy
_version_ 1718374340175593472